Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example.
about
Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Can we improve the performance ...... atoid arthritis as an example.
@en
Can we improve the performance ...... atoid arthritis as an example.
@en-gb
Can we improve the performance ...... atoid arthritis as an example.
@nl
type
label
Can we improve the performance ...... atoid arthritis as an example.
@en
Can we improve the performance ...... atoid arthritis as an example.
@en-gb
Can we improve the performance ...... atoid arthritis as an example.
@nl
prefLabel
Can we improve the performance ...... atoid arthritis as an example.
@en
Can we improve the performance ...... atoid arthritis as an example.
@en-gb
Can we improve the performance ...... atoid arthritis as an example.
@nl
P2093
P2860
P50
P1476
Can we improve the performance ...... atoid arthritis as an example.
@en
P2093
Arthur Kavanaugh
Daniel Aletaha
Michael E Weinblatt
Robert B M Landewé
Roy Fleischmann
P2860
P304
P356
10.1136/ANNRHEUMDIS-2014-205821
P407
P577
2014-08-11T00:00:00Z
P5875
P6179
1005830202